Navigation Links
Echo Therapeutics Announces Strategic Partnership with Medical Technologies Innovation Asia (MTIA)
Date:12/10/2013

ough this joint process took more time than all three parties initially anticipated, its comprehensive and cooperative nature has been highly beneficial to the alignment of our interests and that of all of our shareholders," added Robert Doman.

About Medical Technologies Innovation Asia

Medical Technologies Innovation Asia (MTIA) is a fully integrated medical device company focused on accelerating and delivering game-changing technologies that improve existing standards of care to meet unmet significant clinical needs and challenges, especially in oncology, diabetic, cardiovascular and other aging-related disease. Headquartered in Hong Kong, the company has manufacturing and sales facilities throughout mainland China. MTIA has established sales channels in more than 1,000 hospitals across China's provinces, including national, top-tier regional and military institutions. MTIA is also the leading investor to pilot a number of State-Owned Enterprise giants of China in the healthcare area plus one of the potentially biggest market capitalization pharmaceutical companies who also has dramatic marketing and sales presence in the diabetic and cardiovascular disease treatment field. 

About Echo Therapeutics

Echo Therapeutics is developing the Symphony CGM System as a non-invasive, wireless, continuous glucose monitoring system for use initially in the critical care setting. Significant opportunity also exists for Symphony to be used in the hospital beyond the critical care setting, as well as in patients with diabetes in the outpatient setting. Echo is also developing its needle-free skin preparation component of Symphony, the Prelude® SkinPrep System, as a platform technology to enhance delivery of topical pharmaceuticals.

Cautionary Statement Regarding Forward Looking Statem
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Larry J. Merlo , President and CEO of CVS ... National Press Club in Washington, D.C. ... selling tobacco products and its leadership in driving the innovations ... changes in our health care system pose enormous challenges to ... "CVS Health has a truly unique combination of business assets ...
(Date:9/19/2014)... WALTHAM, Mass. , Sept. 19, 2014  Alere ... in rapid diagnostics, issued the following statement today in ... Combating Antibiotic-Resistant Bacteria. "As the global leader ... President for establishing a national strategy to address the ... continuing to work with the Administration on initiatives to ...
(Date:9/19/2014)... DIEGO , Sept. 19, 2014  Lpath, ... leader in bioactive lipid-targeted therapeutics, announced today that ... 3,605,042 registered shares of common stock and 3,605,042 ... combined purchase price for one registered share of ... one unregistered share of common stock will be ...
Breaking Medicine Technology:CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
... PLEASANTON, Calif., Dec. 2 Roche (SIX: RO, ROG; OTCQX: ... Administration (FDA) approved an additional intended use for its licensed ... of up to 96 individual donations. The test, called the ... s 201 system, is a qualitative, in-vitro test for ...
... , NANJING, China, Dec. 2 ... SCR ), a leading pharmaceutical company,specializing in ... pharmaceuticals in China, today reported that its,subsidiary Jiangsu Yanshen ... of all its products in order to conduct an,internal ...
Cached Medicine Technology:FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3
(Date:9/20/2014)... (PRWEB) September 21, 2014 Increases ... contributing to greater waste treatment volumes. However, government ... diverting waste from landfill. According to IBISWorld industry ... have implemented strategies aimed at reducing the volume ... waste recycled and recovered.” Still, a large proportion ...
(Date:9/20/2014)... New York, NY (PRWEB) September 20, 2014 ... Ariana Grande concert tickets. This popular ticket ... added savings. , Ariana Grande is nearing that next step ... is already considered a superstar in the music and entertainment ... who recently released her second straight No. 1 album, will ...
(Date:9/20/2014)... 20, 2014 As testosterone lawsuit ... federal court, Bernstein Liebhard LLP notes that advisors ... have voted overwhelmingly to recommend that prescription medications ... subjected to further study in order to investigate ... on September 18th by Bloomberg.com, the panel of ...
(Date:9/20/2014)... September 20, 2014 Lifeinsurancequoteterm.net has ... a no medical exam life insurance plan provides for ... vulnerable family members should be a top priority for ... life insurance without taking medical examinations and visiting a ... require medical examinations will provide coverage up to $300,000, ...
(Date:9/20/2014)... 20, 2014 (HealthDay News) -- As flu season approaches, ... is to get a flu shot and a checkup, ... primary care doctor can vaccinate people against the flu, ... may have. Retail stores may provide flu shots for ... said Dr. Jorge Parada, medical director of infection prevention ...
Breaking Medicine News(10 mins):Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2Health News:Get a Flu Shot During Checkup, Doctor Says 2
... they come up seven: on Saturday thousands of newlyweds-to-be will descend ... holds the key to marital bliss. ,In the wedding ... on Saturday, July 7, 2007 -- 7/7/7 -- placing their bets ... that have hosted weddings for decades and at large glitzy resorts ...
... adult neural stem cells, which exist in the brain throughout ... are a diverse group of cells, each capable of giving ... says, significantly shifts the perspective on how these cells could ... results of their study are reported online in "Science Express" ...
... going abroad who suffer from food allergies can find ... wordlist of more than 200 ingredients , from nuts ... translated into 30 languages. ,The list, available ... ordering a meal and to compare ingredients on food ...
... an abrupt end when a guest discovered bodies in the freezer. ... 46, and son Bryan 11. ,The female guest ... with a group of friends Tuesday at the man's home in ... the bodies. ,The guest fled the house and ...
... announced that with the initiation of a new study ... it will accelerate the recruitment of patients in the ... novel small molecule vascular disruption agent (VDA) and apoptosis ... tumors and lymphomas. The first two cohorts of patients ...
... feared H5N1 strain of bird flu which can kill huamns in ... in the state of Saxony-Anhalt said 38 dead birds found on ... had all tested positive. ,Saxony-Anhalt is the fourth of ... late last month, when it struck down six wild birds in ...
Cached Medicine News:Health News:Will Seven Be the Lucky Number for Las Vegas Newlyweds? 2Health News:Insight Into Neural Stem Cells Has Implications For Designing Therapies 2Health News:Insight Into Neural Stem Cells Has Implications For Designing Therapies 3Health News:Insight Into Neural Stem Cells Has Implications For Designing Therapies 4Health News:Dinner Guest Recover Bodies in Freezer 2Health News:EpiCept Accelerates Development of Phase I Clinical Study for Cancer 2
Standard vice clamp, can be fitted instead of Quick Realease Cassette...
... freezing stage is a refrigerated design for use ... for use with the 8000 sledge microtome, however, ... ,The refrigerated stage gives a large working area ... ridged to provide good adhesion between the specimen ...
... work, it is necessary to cool a specimen ... be fitted to most microtomes and will permit ... depending on conditions. The equipment consists of a ... stage is best suited for operation with a ...
... MNL 4404 & 4405 series Freezing Stages ... devices have no moving parts and need only ... water for operation. Freezing starts immediately ... is adjustable so that optimum cutting temperatures can ...
Medicine Products: